NYSEMKT: PTHSPelthos Therapeutics Inc Stock Ownership - Who owns Pelthos Therapeutics?
Insider buying vs selling
Have Pelthos Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Matthew Pauls | Director | 2026-04-02 | 371 | $21.36 | $7.93kSell |
| Ezra M. Friedberg | Director | 2026-04-02 | 293 | $20.51 | $6.01kSell |
| Ezra M. Friedberg | Director | 2026-04-02 | 265 | $21.36 | $5.66kSell |
| Peter Greenleaf | Director | 2026-04-02 | 420 | $20.52 | $8.62kSell |
| Peter Greenleaf | Director | 2026-04-02 | 377 | $21.36 | $8.05kSell |
| Richard Malamut | Director | 2026-04-02 | 310 | $20.51 | $6.36kSell |
| Richard Malamut | Director | 2026-04-02 | 280 | $21.36 | $5.98kSell |
| Matthew Pauls | Director | 2026-04-02 | 415 | $20.52 | $8.51kSell |
| Ezra M. Friedberg | Director | 2025-11-25 | 5,999 | $28.00 | $167.97kSell |
| Ezra M. Friedberg | Director | 2025-11-25 | 2,000 | $28.14 | $56.27kSell |
PTHS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PTHS insiders and whales buy or sell their stock.
PTHS Shareholders
What type of owners hold Pelthos Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Todd C. Davis | 44.79% | 1,502,917 | $38.32M | Insider |
| Ligand Pharmaceuticals Inc | 44.70% | 1,500,000 | $38.24M | Insider |
| Ezra M. Friedberg | 21.60% | 724,818 | $18.48M | Insider |
| Motif Pharmaceuticals Ltd | 14.03% | 470,674 | $12.00M | Insider |
| Boswell Prayer Ltd | 13.71% | 459,895 | $11.73M | Insider |
| Aperture Healthcare Ventures Ltd | 12.71% | 426,566 | $10.88M | Insider |
| Ame Equities LLC | 10.47% | 351,163 | $8.95M | Insider |
| Murchinson Ltd | 8.63% | 289,479 | $7.38M | Institution |
| Ikarian Capital LLC | 7.62% | 255,758 | $6.52M | Institution |
| Scott M. Plesha | 2.49% | 83,678 | $2.13M | Insider |
PTHS vs Biotech Stocks
Pelthos Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.